Cargando…
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
INTRODUCTION: Experimental and clinical evidence points to a critical role of progesterone and the nuclear progesterone receptor (PR) in controlling mammary gland tumorigenesis. However, the molecular mechanisms of progesterone action in breast cancer still remain elusive. On the other hand, micro R...
Autores principales: | Rivas, Martin A, Venturutti, Leandro, Huang, Yi-Wen, Schillaci, Roxana, Huang, Tim Hui-Ming, Elizalde, Patricia V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446340/ https://www.ncbi.nlm.nih.gov/pubmed/22583478 http://dx.doi.org/10.1186/bcr3187 |
Ejemplares similares
-
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth
por: Izzo, Franco, et al.
Publicado: (2014) -
Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010) -
Downregulation of miR-16 via URGCP pathway contributes to glioma growth
por: Hong, Liang, et al.
Publicado: (2017) -
CRKL oncogene is downregulated by p53 through miR-200s
por: Tamura, Miyuki, et al.
Publicado: (2015) -
HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96
por: Feng, Jin, et al.
Publicado: (2014)